These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8952603)

  • 41. Association of novel promoter single nucleotide polymorphisms in vasopressin V1a receptor gene with essential hypertension in nonobese Japanese.
    Hasan KN; Shoji M; Sugimoto K; Tsutaya S; Matsuda E; Kudo R; Nakaji S; Suda T; Yasujima M
    J Hum Hypertens; 2007 Oct; 21(10):825-7. PubMed ID: 17653244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel missense mutation, F826Y, in the mineralocorticoid receptor gene in Japanese hypertensives: its implications for clinical phenotypes.
    Kamide K; Yang J; Kokubo Y; Takiuchi S; Miwa Y; Horio T; Tanaka C; Banno M; Nagura J; Okayama A; Tomoike H; Kawano Y; Miyata T
    Hypertens Res; 2005 Sep; 28(9):703-9. PubMed ID: 16419642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Molecular cloning and functional expression of glucagon receptors in the liver, the heart and various other tissues].
    Christophe J
    Bull Mem Acad R Med Belg; 1994; 149(5-7):271-7; discussion 277-8. PubMed ID: 7795550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone action.
    Day JW; Li P; Patterson JT; Chabenne J; Chabenne MD; Gelfanov VM; Dimarchi RD
    J Pept Sci; 2011 Mar; 17(3):218-25. PubMed ID: 21308878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes.
    Ali S; Drucker DJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E415-21. PubMed ID: 19116373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucagon receptor signaling is essential for control of murine hepatocyte survival.
    Sinclair EM; Yusta B; Streutker C; Baggio LL; Koehler J; Charron MJ; Drucker DJ
    Gastroenterology; 2008 Dec; 135(6):2096-106. PubMed ID: 18809404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of insulin-like growth factor-1 receptor gene polymorphisms with left ventricular mass and geometry in essential hypertension.
    Horio T; Kamide K; Takiuchi S; Yoshii M; Miwa Y; Matayoshi T; Yoshihara F; Nakamura S; Tokudome T; Miyata T; Kawano Y
    J Hum Hypertens; 2010 May; 24(5):320-6. PubMed ID: 19759555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and characterization of a glucagon receptor from the goldfish Carassius auratus: implications for the evolution of the ligand specificity of glucagon receptors in vertebrates.
    Chow BK; Moon TW; Hoo RL; Yeung CM; Müller M; Christos PJ; Mojsov S
    Endocrinology; 2004 Jul; 145(7):3273-88. PubMed ID: 15033912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of key residues for the binding of glucagon to the N-terminal domain of its receptor: an alanine scan and modeling study.
    Prévost M; Vertongen P; Waelbroeck M
    Horm Metab Res; 2012 Oct; 44(11):804-9. PubMed ID: 22893257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain.
    Chowen JA; de Fonseca FR; Alvarez E; Navarro M; García-Segura LM; Blázquez E
    Neuropeptides; 1999 Jun; 33(3):212-5. PubMed ID: 10657494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The glucagon-like peptide-1 receptor--or not?
    Pyke C; Knudsen LB
    Endocrinology; 2013 Jan; 154(1):4-8. PubMed ID: 23267050
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes.
    Jia Y; Liu Y; Feng L; Sun S; Sun G
    Front Endocrinol (Lausanne); 2022; 13():928016. PubMed ID: 35784565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucagon receptor gene mutation in essential hypertension.
    Chambers SM; Morris BJ
    Nat Genet; 1996 Feb; 12(2):122. PubMed ID: 8563746
    [No Abstract]   [Full Text] [Related]  

  • 54. [Glucagon-like peptide-1 (GLP-1) receptor gene].
    Taminato T; Yagi T; Nishi S
    Nihon Rinsho; 1997 Oct; 55 Suppl():432-6. PubMed ID: 9392144
    [No Abstract]   [Full Text] [Related]  

  • 55. Gly40Ser mutation of glucagon receptor gene and essential hypertension in Japanese.
    Fujisawa T; Ikegami H; Babaya N; Ogihara T
    Hypertension; 1996 Dec; 28(6):1100. PubMed ID: 8952603
    [No Abstract]   [Full Text] [Related]  

  • 56. Screening for the Gly40Ser mutation in the glucagon receptor gene among patients with type 2 diabetes or essential hypertension in Taiwan.
    Huang CN; Lee KC; Wu HP; Tai TY; Lin BJ; Chuang LM
    Pancreas; 1999 Mar; 18(2):151-5. PubMed ID: 10090412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects.
    Morris BJ; Jeyasingam CL; Zhang W; Curtain RP; Griffiths LR
    Hypertension; 1997 Dec; 30(6):1640-1. PubMed ID: 9403595
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.